The ontogeny and fate of NK cells marked by permanent DNA rearrangements

Journal of Immunology

Volumn 180, Issue 3, 2008, Pages 1432-1441

  Pilbeam, Kristy ^a   Basse, Per ^a   Brossay, Laurent ^d   Vujanovic, Nikola ^b   Gerstein, Rachel ^e   Vallejo, Abbe N ^c   Borghesi, Lisa ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d BROWN UNIVERSITY   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; DNA; GAMMA INTERFERON; RAG1 PROTEIN; STAT5 PROTEIN; DNA BINDING PROTEIN; HOMEODOMAIN PROTEIN; RAG 1 PROTEIN; RAG-1 PROTEIN; RAG2 PROTEIN, MOUSE; RECOMBINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BIOLOGICAL ACTIVITY; BONE MARROW; CARCINOGENESIS; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOLYSIS; DEVELOPMENTAL STAGE; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; IN VIVO STUDY; MOUSE; MULTIPOTENT STEM CELL; NATURAL KILLER CELL; NONHUMAN; ONTOGENY; PHOSPHORYLATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REACTION ANALYSIS; T LYMPHOCYTE; TARGET CELL; ANIMAL; CELL LINEAGE; ENZYMOLOGY; GENE REARRANGEMENT; GENETIC RECOMBINATION; GENETICS; IMMUNOLOGY; METABOLISM; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD56; CELL LINEAGE; DNA-BINDING PROTEINS; GENE REARRANGEMENT; HOMEODOMAIN PROTEINS; HUMANS; KILLER CELLS, NATURAL; MICE; MICE, TRANSGENIC; MULTIPOTENT STEM CELLS; PHOSPHORYLATION; RECOMBINATION, GENETIC; STAT5 TRANSCRIPTION FACTOR; VDJ RECOMBINASES;

EID: 40749143994     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.3.1432     Document Type: Article

References (47)

1. Borghesi, L., L. Y. Hsu, J. P. Miller, M. Anderson, L. Herzenberg, M. S. Schlissel, D. Allman, and R. M. Gerstein. 2004. B lineage-specific regulation of V(D)J recombinase activity is established in common lymphoid progenitors. J. Exp. Med. 199: 491-502.
2. Igarashi, H., S. C. Gregory, T. Yokota, N. Sakaguchi, and P. W. Kincade. 2002. Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. Immunity 17: 117-130.
3. Corcoran, L., I. Ferrero, D. Vremec, K. Lucas, J. Waithman, M. O'Keeffe, L. Wu, A. Wilson, and K. Shortman. 2003. The lymphoid past of mouse plasmacytoid cells and thymic dendritic cells. J. Immunol. 170: 4926-4932.
4. Veinotte, L. L., C. P. Greenwood, N. Mohammadi, C. A. Parachoniak, and F. Takei. 2006. Expression of rearranged TCRγ genes in natural killer cells suggests a minor thymus-dependent pathway of lineage commitment. Blood 107: 2673-2679.
5. Fronkova, E., O. Krejci, T. Kalina, O. Horvath, J. Trka, and O. Hrusak. 2005. Lymphoid differentiation pathways can be traced by TCR δ rearrangements. J. Immunol. 175: 2495-2500.
6. Borghesi, L., and C. Milcarek. 2007. Innate versus adaptive immunity: a paradigm past its prime? Cancer Res. 67: 3989-3993.
7. Puellmann, K., W. E. Kaminski, M. Vogel, C. T. Nebe, J. Schroeder, H. Wolf, and A. W. Beham. 2006. From the cover: a variable immunoreceptor in a subpopulation of human neutrophils. Proc. Natl. Acad. Sci. USA 103: 14441-14446.
8. Yanagi, Y., N. Caccia, M. Kronenberg, B. Chin, J. Roder, D. Rohel, T. Kiyohara, R. Lauzon, B. Toyonaga, K. Rosenthal, et al. 1985. Gene rearrangement in cells with natural killer activity and expression of the β-chain of the T-cell antigen receptor. Nature 314: 631-633.
9. Biron, C. A., P. van den Elsen, M. M. Tutt, P. Medveczky, V. Kumar, and C. Terhorst. 1987. Murine natural killer cells stimulated in vivo do not express the T cell receptor α, β, γ, T3 δ, or T3 ε genes. J. Immunol. 139: 1704-1710.
10. Lanier, L. L., S. Cwirla, N. Federspiel, and J. H. Phillips. 1986. Human natural killer cells isolated from peripheral blood do not rearrange T cell antigen receptor β chain genes. J. Exp. Med. 163: 209-214.
11. Tutt, M. M., W. A. Kuziel, J. Hackett, Jr., M. Bennett, P. W. Tucker, and V. Kumar. 1986. Murine natural killer cells do not express functional transcripts of the α-, β-, or γ-chain genes of the T cell receptor. J. Immunol. 137: 2998-3001.
12. Dorshkind, K., S. B. Pollack, M. J. Bosma, and R. A. Phillips. 1985. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (SCID). J. Immunol. 134: 3798-3801.
13. O'Leary, J. G., M. Goodarzi, D. L. Drayton, and U. H. von Andrian. 2006. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 7: 507-516.
14. Shinkai, Y., G. Rathbun, K. P. Lam, E. M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A. M. Stall, et al. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68: 855-867.
15. Vosshenrich, C. A., T. Ranson, S. I. Samson, E. Corcuff, F. Colucci, E. E. Rosmaraki, and J. P. Di Santo. 2005. Roles for common cytokine receptor γ-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J. Immunol. 174: 1213-1221.
16. Pilbeam, K., N. Vujanovic, and L. Borghesi. 2007. Ontogeny of natural killer cells in man and mouse. In Everything You Wanted to Know about NK Cells but Were Afraid to Ask. L. Brossay, ed. Transworld Research Network, Kerala, India, pp. 1-26.
17. Rumfelt, L. L., Y. Zhou, B. M. Rowley, S. A. Shinton, and R. R. Hardy. 2006. Lineage specification and plasticity in CD19- early B cell precursors. J. Exp. Med. 203: 675-687.
18. Borghesi, L., J. Aites, S. Nelson, P. Lefterov, P. James, and R. Gerstein. 2005. E47 is required for V(D)J recombinase activity in common lymphoid progenitors. J. Exp. Med. 202: 1669-1677.
19. Borghesi, L., and R. M. Gerstein. 2004. Developmental separation of V(D)J recombinase expression and initiation of IgH recombination in B lineage progenitors in vivo. J. Exp. Med. 199: 483-489.
20. Robbins, S. H., M. S. Tessmer, T. Mikayama, and L. Brossay. 2004. Expansion and contraction of the NK cell compartment in response to murine cytomegalovirus infection. J. Immunol. 173: 259-266.
21. Anderson, M. T., N. Baumgarth, R. P. Haugland, R. M. Gerstein, T. Tjioe, and L. A. Herzenberg. 1998. Pairs of violet-light-excited fluorochromes for flow cytometric analysis. Cytometry 33: 435-444.
22. Allman, D. M., S. E. Ferguson, V. M. Lentz, and M. P. Cancro. 1993. Peripheral B cell maturation: II. Heat-stable antigen(hi) splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. J. Immunol. 151: 4431-4444.
23. Pillarisetty, V. G., S. C. Katz, J. I. Bleier, A. B. Shah, and R. P. Dematteo. 2005. Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-γ via autocrine IL-12. J. Immunol. 174: 2612-2618.
24. Piccioli, D., S. Sbrana, E. Melandri, and N. M. Valiante. 2002. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195: 335-341.
25. Yang, Q., M. E. Hokland, J. L. Bryant, Y. Zhang, U. Nannmark, S. C. Watkins, R. H. Goldfarb, R. B. Herberman, and P. H. Basse. 2003. Tumor-localization by adoptively transferred, interleukin-2-activated NK cells leads to destruction of well-established lung metastases. Int. J. Cancer 105: 512-519.
26. Krutzik, P. O., M. B. Hale, and G. P. Nolan. 2005. Characterization of the murine immunological signaling network with phosphospecific flow cytometry. J. Immunol. 175: 2366-2373.
27. Krejci, O., Z. Prouzova, O. Horvath, J. Trka, and O. Hrusak. 2003. Cutting edge: TCR δ gene is frequently rearranged in adult B lymphocytes. J. Immunol. 171: 524-527.
28. Muschen, M., D. Re, B. Jungnickel, V. Diehl, K. Rajewsky, and R. Kuppers. 2000. Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J. Exp. Med. 192: 1833-1840.
29. Pongers-Willemse, M. J., T. Seriu, F. Stolz, E. d'Aniello, P. Gameiro, P. Pisa, M. Gonzalez, C. R. Bartram, E. R. Panzer-Grumayer, A. Biondi, et al. 1999. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the biomed-1 concerted action: investigation of minimal residual disease in acute leukemia. Leukemia 13: 110-118.
30. Domen, J., K. L. Gandy, and I. L. Weissman. 1998. Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood 91: 2272-2282.
31. Kee, B. L., G. Bain, and C. Murre. 2002. IL-7Rαand E47: independent pathways required for development of multipotent lymphoid progenitors. EMBO J. 21: 103-113.
32. Kondo, M., K. Akashi, J. Domen, K. Sugamura, and I. L. Weissman. 1997. Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common γ chain-deficient mice. Immunity 7: 155-162.
33. Ranson, T., C. A. Vosshenrich, E. Corcuff, O. Richard, W. Muller, and J. P. Di Santo. 2003. IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood 101: 4887-4893.
34. Vosshenrich, C. A., M. E. Garcia-Ojeda, S. I. Samson-Villeger, V. Pasqualetto, L. Enault, O. Richard-Le Goff, E. Corcuff, D. Guy-Grand, B. Rocha, A. Cumano, et al. 2006. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat. Immunol. 7: 1217-1224.
35. Hayakawa, Y., and M. J. Smyth. 2006. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 176: 1517-1524.
36. Stewart, C. A., T. Walzer, S. H. Robbins, B. Malissen, E. Vivier, and I. Prinz. 2007. Germ-line and rearranged Tcrd transcription distinguish bona fide NK cells and NK-like γδ T cells. Eur. J. Immunol. 37: 1442-1452.
37. + subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity 22: 295-304.
38. Freud, A. G., A. Yokohama, B. Becknell, M. T. Lee, H. C. Mao, A. K. Ferketich, and M. A. Caligiuri. 2006. Evidence for discrete stages of human natural killer cell differentiation in vivo. J. Exp. Med. 203: 1033-1043.
39. Lewis, S. M., E. Agard, S. Suh, and L. Czyzyk. 1997. Cryptic signals and the fidelity of V(D)J joining. Mol. Cell. Biol. 17: 3125-3136.
40. Finette, B. A., T. Poseno, and R. J. Albertini. 1996. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children. Cancer Res. 56: 1405-1412.
41. Murray, J. M., J. P. O'Neill, T. Messier, J. Rivers, V. E. Walker, B. McGonagle, L. Trombley, L. G. Cowell, G. Kelsoe, F. McBlane, and B. A. Finette. 2006. V(D)J recombinase-mediated processing of coding junctions at cryptic recombination signal sequences in peripheral T cells during human development. J. Immunol. 177: 5393-5404.
42. Cowell, L. G., M. Davila, K. Yang, T. B. Kepler, and G. Kelsoe. 2003. Prospective estimation of recombination signal efficiency and identification of functional cryptic signals in the genome by statistical modeling. J. Exp. Med. 197: 207-220.
43. Nagaoka, H., G. Gonzalez-Aseguinolaza, M. Tsuji, and M. C. Nussenzweig. 2000. Immunization and infection change the number of recombination activating gene (RAG)-expressing B cells in the periphery by altering immature lymphocyte production. J. Exp. Med. 191: 2113-2120.
44. Harman, B. C., J. P. Miller, N. Nikbakht, R. Gerstein, and D. Allman. 2006. Mouse plasmacytoid dendritic cells derive exclusively from estrogen-resistant myeloid progenitors. Blood 108: 878-885.
45. Marculescu, R., K. Vanura, B. Montpellier, S. Roulland, T. Le, J. M. Navarro, U. Jager, F. McBlane, and B. Nadel. 2006. Recombinase, chromosomal translocations and lymphoid neoplasia: targeting mistakes and repair failures. DNA Repair 5: 1246-1258.
46. Behbod, F., and J. M. Rosen. 2005. Will cancer stem cells provide new therapeutic targets? Carcinogenesis 26: 703-711.
47. Santucci, M., N. Pimpinelli, D. Massi, M. E. Kadin, C. J. Meijer, H. K. Muller-Hermelink, M. Paulli, J. Wechsler, R. Willemze, H. Audring, et al. 2003. Cytotoxic/natural killer cell cutaneous lymphomas: report of EORTC cutaneous lymphoma task force workshop. Cancer 97: 610-627.